Zinc transporters and zinc signaling: New insights into their role in type 2 diabetes

International Journal of Endocrinology

Volumn 2015, Issue , 2015, Pages

  Myers, Stephen A ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PROTEIN ZIP1; PROTEIN ZIP10; PROTEIN ZIP11; PROTEIN ZIP12; PROTEIN ZIP13; PROTEIN ZIP14; PROTEIN ZIP2; PROTEIN ZIP3; PROTEIN ZIP4; PROTEIN ZIP5; PROTEIN ZIP6; PROTEIN ZIP7; PROTEIN ZIP8; PROTEIN ZIP9; PROTEIN ZNT1; PROTEIN ZNT10; PROTEIN ZNT2; PROTEIN ZNT3; PROTEIN ZNT4; PROTEIN ZNT5; PROTEIN ZNT6; PROTEIN ZNT7; PROTEIN ZNT8; PROTEIN ZNT9; SOLUTE LINKED CARRIER 30; SOLUTE LINKED CARRIER 39; UNCLASSIFIED DRUG; ZINC; ZINC TRANSPORTER;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; DRUG EFFICACY; HORMONE ACTION; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; SUPPLEMENTATION;

EID: 84929339981     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2015/167503     Document Type: Review

References (88)

1. G. Casey, "The sugar disease-understanding type 2 diabetes mellitus, " Kai TiakiNursingNewZealand, vol. 17, no. 2, pp. 16-21, 2011.
2. G. Smushkin and A. Vella, "What is type 2 diabetes" Medicine, vol. 38, no. 11, pp. 597-601, 2010.
3. A. Bagnasco, P. diGiacomo, R. da RinDellaMora et al., "Factors influencing self-management in patients with type 2 diabetes: a quantitative systematic review protocol, " Journal of Advanced Nursing, vol. 70, no. 1, pp. 187-200, 2014.
4. H. Shen, H. Edwards, M. Courtney, J. Mcdowell, and J. Wei, "Barriers and facilitators to diabetes self-management: perspectives of older community dwellers and health professionals in China, " International Journal of Nursing Practice, vol. 19, no. 6, pp. 627-635, 2013.
5. T. Fukada, S. Yamasaki, K. Nishida, M. Murakami, and T. Hirano, "Zinc homeostasis and signaling in health and diseases, " Journal of Biological Inorganic Chemistry, vol. 16, no. 7, pp. 1123-1134, 2011.
6. H. Haase and L. Rink, "Zinc signaling, " in Zinc in Human Health, L. Rink, Ed., p. 577, IOS Press, Amsterdam, The Netherlands, 2011.
7. H. Haase and W. Maret, "Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling, " Experimental Cell Research, vol. 291, no. 2, pp. 289-298, 2003.
8. H. Haase andW. Maret, "Fluctuations of cellular, available zinc modulate insulin signaling via inhibition of protein tyrosine phosphatases, " Journal of Trace Elements in Medicine and Biology, vol. 19, no. 1, pp. 37-42, 2005.
9. J. Jansen, E. Rosenkranz, S. Overbeck et al., "Disturbed zinc homeostasis in diabetic patients by in vitro and in vivo analysis of insulinomimetic activity of zinc, " Journal of Nutritional Biochemistry, vol. 23, no. 11, pp. 1458-1466, 2012.
10. J. C. King, D. M. Shames, and L. R. Woodhouse, "Zinc homeostasis in humans, " The Journal of Nutrition, vol. 130, no. 5, pp. 1360S-1366S, 2000.
11. Y. Yoshikawa, E. Ueda, Y. Kojima, and H. Sakurai, "The action mechanism of zinc(II) complexes with insulinomimetic activity in rat adipocytes, " Life Sciences, vol. 75, no. 6, pp. 741-751, 2004.
12. S. Yamasaki, K. Sakata-Sogawa, A. Hasegawa et al., "Zinc is a novel intracellular second messenger, " The Journal of Cell Biology, vol. 177, no. 4, pp. 637-645, 2007.
13. X.-H. Tang and N. F. Shay, "Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes, " Journal of Nutrition, vol. 131, no. 5, pp. 1414-1420, 2001.
14. H. P. Roth andM. Kirchgessner, "Zinc and insulinmetabolism, " Biological Trace Element Research, vol. 3, no. 1, pp. 13-32, 1981.
15. S. A. Myers, A. Nield, and M. Myers, "Zinc transporters, mechanisms of action and therapeutic utility: implications for type 2 diabetes mellitus, " Journal of Nutrition and Metabolism, vol. 2012, Article ID173712, 13 pages, 2012.
16. J. M.May and C. S. Contoreggi, "The mechanism of the insulinlike effects of ionic zinc, "The Journal of Biological Chemistry, vol. 257, no. 8, pp. 4362-4368, 1982.
17. E.Mocchegiani, R.Giacconi, and M.Malavolta, "Zinc signalling and subcellular distribution: emerging targets in type 2 diabetes, " Trends inMolecularMedicine, vol. 14, no. 10, pp. 419-428, 2008.
18. C. T. Chasapis, C. A. Spiliopoulou, A. C. Loutsidou, and M. E. Stefanidou, "Zinc and human health: an update, " Archives of Toxicology, vol. 86, no. 4, pp. 521-534, 2012.
19. J. Jansen, W. Karges, and L. Rink, "Zinc and diabetes-clinical links and molecular mechanisms, " Journal of Nutritional Biochemistry, vol. 20, no. 6, pp. 399-417, 2009.
20. W. Maret, "Analyzing free zinc(ii) ion concentrations in cell biology with fluorescent chelating molecules, " Metallomics, vol. 7, no. 2, pp. 202-211, 2015.
21. K. R. Gee, Z.-L. Zhou, W.-J. Qian, and R. Kennedy, "Detection and imaging of zinc secretion from pancreatic,-cells using a new fluorescent zinc indicator, " Journal of the American Chemical Society, vol. 124, no. 5, pp. 776-778, 2002.
22. E. Tomat and S. J. Lippard, "Imaging mobile zinc in biology, " Current Opinion in Chemical Biology, vol. 14, no. 2, pp. 225-230, 2010.
23. J. A. L. Figueroa, K. S. Vignesh, G. S. Deepe Jr., and J. Caruso, "Selectivity and specificity of small molecule fluorescent dyes/probes used for the detection of Zn2+ and Ca2+ in cells, " Metallomics, vol. 6, no. 2, pp. 301-315, 2014.
24. I. A. Brand and J. Kleineke, "Intracellular zinc movement and its effect on the carbohydrate metabolism of isolated rat hepatocytes, " The Journal of Biological Chemistry, vol. 271, no. 4, pp. 1941-1949, 1996.
25. A.Krezel andW.Maret, "Zinc-buffering capacity of a eukaryotic cell at physiological pZn, " Journal of Biological Inorganic Chemistry, vol. 11, no. 8, pp. 1049-1062, 2006.
26. R. A. Bozym, R. B.Thompson, A. K. Stoddard, and C. A. Fierke, "Measuring picomolar intracellular exchangeable zinc in PC-12 cells using a ratiometric fluorescence biosensor, " ACS Chemical Biology, vol. 1, no. 2, pp. 103-111, 2006.
27. P. J. Dittmer, J. G. Miranda, J. A. Gorski, and A. E. Palmer, "Genetically encoded sensors to elucidate spatial distribution of cellular zinc, " Journal of Biological Chemistry, vol. 284, no. 24, pp. 16289-16297, 2009.
28. W. Maret, "Metals on the move: zinc ions in cellular regulation and in the coordination dynamics of zinc proteins, " BioMetals, vol. 24, no. 3, pp. 411-418, 2011.
29. R. J. Cousins, J. P. Liuzzi, and L. A. Lichten, "Mammalian zinc transport, trafficking, and signals, " The Journal of Biological Chemistry, vol. 281, no. 34, pp. 24085-24089, 2006.
30. D. J. Eide, "Zinc transporters and the cellular trafficking of zinc, " Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1763, no. 7, pp. 711-722, 2006.
31. L. A. Gaither and D. J. Eide, "Eukaryotic zinc transporters and their regulation, " BioMetals, vol. 14, no. 3-4, pp. 251-270, 2001.
32. T. Kambe, "An overview of a wide range of functions of ZnT and Zip Zinc transporters in the secretory pathway, " Bioscience, Biotechnology and Biochemistry, vol. 75, no. 6, pp. 1036-1043, 2011.
33. L. A. Lichten and R. J. Cousins, "Mammalian zinc transporters: nutritional and physiologic regulation, " Annual ReviewofNutrition, vol. 29, no. 1, pp. 153-176, 2009.
34. J. P. Liuzzi and R. J. Cousins, "Mammalian zinc transporters, " Annual Review of Nutrition, vol. 24, no. 1, pp. 151-172, 2004.
35. J. Rungby, "Zinc, zinc transporters and diabetes, " Diabetologia, vol. 53, no. 8, pp. 1549-1551, 2010.
36. D. J. Eide, "An 'inordinate fondness for transporters' explained" Science Signaling, vol. 5, no. 210, p. pe5, 2012.
37. J. Jeong and D. J. Eide, "The SLC39 family of zinc transporters, " Molecular Aspects ofMedicine, vol. 34, no. 2-3, pp. 612-619, 2013.
38. B. Milon, Q. Wu, J. Zou, L. C. Costello, and R. B. Franklin, "Histidine residues in the region between transmembrane domains III and IV of hZip1 are required for zinc transport across the plasma membrane in PC-3 cells, " Biochimica et Biophysica Acta-Biomembranes, vol. 1758, no. 10, pp. 1696-1701, 2006.
39. R. D. Palmiter and S. D. Findley, "Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc, " The EMBO Journal, vol. 14, no. 4, pp. 639-649, 1995.
40. Y. Bi, R. D. Palmiter, K. M. Wood, and Q. Ma, "Induction of metallothionein I by phenolic antioxidants requires metalactivated transcription factor 1 (MTF-1) and zinc, " Biochemical Journal, vol. 380, no. 3, pp. 695-703, 2004.
41. L. Huang and S. Tepaamorndech, "The SLC30 family of zinc transporters-a review of current understanding of their biological and pathophysiological roles, " Molecular Aspects of Medicine, vol. 34, no. 2-3, pp. 548-560, 2013.
42. R. Ilouz, O. Kaidanovich, D. Gurwitz, and H. Eldar-Finkelman, "Inhibition of glycogen synthase kinase-3 by bivalent zinc ions: insight into the insulin-mimetic action of zinc, " Biochemical and Biophysical Research Communications, vol. 295, no. 1, pp. 102-106, 2002.
43. T. Moniz, M. J. Amorim, R. Ferreira et al., "Investigation of the insulin-like properties of zinc(II) complexes of 3-hydroxy-4-pyridinones: identification of a compound with glucose lowering effect in STZ-induced type i diabetic animals, " Journal of Inorganic Biochemistry, vol. 105, no. 12, pp. 1675-1682, 2011.
44. N. Wijesekara, F. Chimienti, and M. B. Wheeler, "Zinc, a regulator of islet function and glucose homeostasis, " Diabetes, Obesity and Metabolism, vol. 11, no. 4, pp. 202-214, 2009.
45. L. Coulston and P. Dandona, "Insulin-like effect of zinc on adipocytes, " Diabetes, vol. 29, no. 8, pp. 665-667, 1980.
46. M. Wilson, C. Hogstrand, and W. Maret, "Picomolar concentrations of free zinc(II) ions regulate receptor protein-tyrosine phosphatase activity, " Journal of Biological Chemistry, vol. 287, no. 12, pp. 9322-9326, 2012.
47. H. Haase and W. Maret, "Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants, " BioMetals, vol. 18, no. 4, pp. 333-338, 2005.
48. S. Tang, H. Le-Tien, B. J. Goldstein, P. Shin, R. Lai, and I. G. Fantus, "Decreased in situ insulin receptor dephosphorylation in hyperglycemia-induced insulin resistance in rat adipocytes, " Diabetes, vol. 50, no. 1, pp. 83-90, 2001.
49. K. M. Taylor, "A distinct role in breast cancer for two LIV-1 family zinc transporters, " Biochemical Society Transactions, vol. 36, no. 6, pp. 1247-1251, 2008.
50. K. M. Taylor, P. Vichova, N. Jordan, S. Hiscox, R. Hendley, andR. I.Nicholson, "ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormoneresistant breast cancer cells, " Endocrinology, vol. 149, no. 10, pp. 4912-4920, 2008.
51. A. R. Cameron, S. Anil, E. Sutherland, J. Harthill, and G. Rena, "Zinc-dependent effects of small molecules on the insulinsensitive transcription factor FOXO1a and gluconeogenic genes, " Metallomics, vol. 2, no. 3, pp. 195-203, 2010.
52. C. Hogstrand, P. Kille, R. I. Nicholson, and K. M. Taylor, "Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase activation, " Trends in Molecular Medicine, vol. 15, no. 3, pp. 101-111, 2009.
53. L. Huang, M. Yan, and C. P. Kirschke, "Over-expression of ZnT7 increases insulin synthesis and secretion in pancreatic-cells by promoting insulin gene transcription, " Experimental Cell Research, vol. 316, no. 16, pp. 2630-2643, 2010.
54. L. Huang, C. P. Kirschke, Y.-A. E. Lay, L. B. Levy, D. E. Lamirande, and P. H. Zhang, "Znt7-null mice are more susceptible to diet-induced glucose intolerance and insulin resistance, " The Journal of Biological Chemistry, vol. 287, no. 40, pp. 33883-33896, 2012.
55. K. Smidt, N. Jessen, A. B. Petersen et al., "SLC30A3 responds to glucose-and zinc variations in-cells and is critical for insulin production and in vivo glucose-metabolism during-cell stress, " PLoS ONE, vol. 4, no. 5, Article ID e5684, 2009.
56. E. A. Bellomo, G.Meur, and G. A. Rutter, "Glucose regulates free cytosolic Zn2+ concentration, Slc39 (ZiP), and metallothionein gene expression in primary pancreatic islet-cells, " Journal of Biological Chemistry, vol. 286, no. 29, pp. 25778-25789, 2011.
57. S. Hojyo, T. Fukada, S. Shimoda et al., "The zinc transporter SLC39A14/ZIP14 controls G-protein coupled receptormediated signaling required for systemic growth, " PLoS ONE, vol. 6, no. 3, Article ID e18059, 2011.
58. S. A. Myers, A. Nield, G.-S. Chew, and M. A. Myers, "The zinc transporter, Slc39a7 (Zip7) is implicated in glycaemic control in skeletalmuscle cells, " PLoSONE, vol. 8, no. 11, Article IDe79316, 2013.
59. K. M. Taylor, S. Hiscox, R. I. Nicholson, C. Hogstrand, and P. Kille, "Cell biology: Protein kinase CK2 triggers cytosolic zinc signaling pathways by phosphorylation of zinc channel ZIP7, " Science Signaling, vol. 5, no. 210, article ra11, 2012.
60. M. Taniguchi, A. Fukunaka, M. Hagihara et al., "Essential role of the zinc transporter ZIP9/SLC39A9 in regulating the activations of Akt and Erk in B-cell receptor signaling pathway in DT40 Cells, " PLoS ONE, vol. 8, no. 3, Article IDe58022, 2013.
61. P. Zimmet, "Review: epidemiology of diabetes-its history in the last 50 years, " The British Journal of Diabetes & Vascular Disease, vol. 2, no. 6, pp. 435-439, 2002.
62. I. Hwang, T. Yoon, C. Kim, B. Cho, S. Lee, and M. K. Song, "Different roles of zinc plus arachidonic acid on insulin sensitivity between high fructose-and high fat-fed rats, " Life Sciences, vol. 88, no. 5-6, pp. 278-284, 2011.
63. R. Jayawardena, P. Ranasinghe, P. Galappatthy, R. L. D. K. Malkanthi, G. R. Constantine, and P. Katulanda, "Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis, " Diabetology andMetabolic Syndrome, vol. 4, no. 1, article 13, 2012.
64. S. F. Simon and C. G. Taylor, "Dietary zinc supplementation attenuates hyperglycemia in db/db mice, " Experimental Biology and Medicine, vol. 226, no. 1, pp. 43-51, 2001.
65. M. K. Song, M. J. Rosenthal, S. Hong et al., "Synergistic antidiabetic activities of zinc, cyclo (His-Pro), and arachidonic acid, " Metabolism: Clinical and Experimental, vol. 50, no. 1, pp. 53-59, 2001.
66. X.Miao, W. Sun, Y. Fu, L. Miao, and L. Cai, "Zinc homeostasis in the metabolic syndrome and diabetes, " Frontiers of Medicine in China, vol. 7, no. 1, pp. 31-52, 2013.
67. Y. Zhao, Y. Tan, J. Dai et al., "Zinc deficiency exacerbates diabetic down-regulation of Akt expression and function in the testis: essential roles of PTEN, PTP1B and TRB3, " Journal of Nutritional Biochemistry, vol. 23, no. 8, pp. 1018-1026, 2012.
68. Y.Yoshikawa, E.Ueda, H. Sakurai, andY.Kojima, "Anti-diabetes effect of Zn(II)/carnitine complex by oral administration, " Chemical and Pharmaceutical Bulletin, vol. 51, no. 2, pp. 230-231, 2003.
69. Y. Adachi, J. Yoshida, Y. Kodera et al., "Oral administration of a zinc complex improves type 2 diabetes and metabolic syndromes, " Biochemical and Biophysical Research Communications, vol. 351, no. 1, pp. 165-170, 2006.
70. F. Chimienti, A. Favier, and M. Seve, "ZnT-8, a pancreatic betacell-specific zinc transporter, " BioMetals, vol. 18, no. 4, pp. 313-317, 2005.
71. D. A. Chistiakov and N. V. Voronova, "Zn2+-transporter-8: a dual role in diabetes, " BioFactors, vol. 35, no. 4, pp. 356-363, 2009.
72. E. Kawasaki, K. Nakamura, G. Kuriya et al., "Zinc transporter 8 autoantibodies in fulminant, acute-onset, and slow-onset patients with type 1 diabetes, "Diabetes/MetabolismResearch and Reviews, vol. 27, no. 8, pp. 895-898, 2011.
73. C.Murgia, C. Devirgiliis, E. Mancini, G. Donadel, P. Zalewski, and G. Perozzi, "Diabetes-linked zinc transporter ZnT8 is a homodimeric protein expressed by distinct rodent endocrine cell types in the pancreas and other glands, " Nutrition, Metabolism and Cardiovascular Diseases, vol. 19, no. 6, pp. 431-439, 2009.
74. T. J. Nicolson, E. A. Bellomo, N. Wijesekara et al., "Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants, " Diabetes, vol. 58, no. 9, pp. 2070-2083, 2009.
75. Z. Shan, W. Bao, Y. Zhang et al., "Interactions between zinc transporter-8 gene (SLC30A8) and plasma zinc concentrations for impaired glucose regulation and type 2 diabetes, " Diabetes, vol. 63, no. 5, pp. 1796-1803, 2014.
76. F. Chimienti, S. Devergnas, F. Pattou et al., "In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion, " Journal of Cell Science, vol. 119, no. 20, pp. 4199-4206, 2006.
77. Y. Fu, W. Tian, E. B. Pratt et al., "Down-regulation of ZnT8 expression in INS-1 rat pancreatic beta cells reduces insulin content and glucose-inducible insulin secretion, " PLoS ONE, vol. 4, no. 5, Article ID e5679, 2009.
78. N.Wijesekara, F. F. Dai, A. B. Hardy et al., "Beta cell-specific Znt8 deletion in mice causesmarked defects in insulin processing, crystallisation and secretion, " Diabetologia, vol. 53, no. 8, pp. 1656-1668, 2010.
79. L. D. Pound, S. A. Sarkar, R. K. P. Benninger et al., "Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion, " Biochemical Journal, vol. 421, no. 3, pp. 371-376, 2009.
80. A. B. Hardy, N. Wijesekara, I. Genkin et al., "Effects of highfat diet feeding on Znt8-null mice: differences between betacell and global knockout of Znt8, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 302, no. 9, pp. E1084-E1096, 2012.
81. U. J. Kommoju and B. M. Reddy, "Genetic etiology of type 2 diabetes mellitus: a review, " International Journal of Diabetes in Developing Countries, vol. 31, no. 2, pp. 51-64, 2011.
82. R. Saxena, B. F. Voight, V. Lyssenko et al., "Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels, " Science, vol. 316, no. 5829, pp. 1331-1336, 2007.
83. R. Sladek, G. Rocheleau, J. Rung et al., "A genome-wide association study identifies novel risk loci for type 2 diabetes, " Nature, vol. 445, no. 7130, pp. 881-885, 2007.
84. J. Xu, J. Wang, and B. Chen, "SLC30A8 (ZnT8) variations and type 2 diabetes in the Chinese Han population, " Genetics and Molecular Research, vol. 11, no. 2, pp. 1592-1598, 2012.
85. E. Kawasaki, "ZnT8 and type 1 diabetes, " Endocrine Journal, vol. 59, no. 7, pp. 531-537, 2012.
86. J. M.Wenzlau, K. Juhl, L. Yu et al., "Thecation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 43, pp. 17040-17045, 2007.
87. J. Flannick, G. Thorleifsson, N. L. Beer et al., "Loss-of-function mutations in SLC30A8 protect against type 2 diabetes, " Nature Genetics, vol. 46, no. 4, pp. 357-363, 2014.
88. M. Foster, A. Chu, P. Petocz, and S. Samman, "Zinc transporter gene expression and glycemic control in post-menopausal women with Type 2 diabetes mellitus, " Journal of Trace Elements in Medicine and Biology, vol. 28, no. 4, pp. 448-452, 2014.